hotspot -WSS

hotspot

author：explore 2025-10-03 00:38:12 - browse：8332

A black and white cutout photo of Feng Zhang on the left of a black and white cutout photo of Alex Aravanis. Both photos are placed on top of yellow geometric shapes and a gradient dark blue background. — Researcher Feng Zhang, left, and Alex Aravanis, the CEO of Moonwalk. Illustration: Christine Kao/STAT; Photo: Katherine Taylor for STAT and Business Wire

A new startup co-founded by CRISPR innovator Feng Zhang, a former executive at Grail and Illumina, and others has raised $57 million to develop a defanged form of gene editing that doesn’t cut the DNA strand.

Moonwalk Therapeutics launched Thursday with funding from Alpha Wave Ventures, ARCH Venture Partners, Future Ventures, Khosla Ventures, GV, and YK Bioventures. It plans to use that money to develop treatments for a variety of diseases, including chronic and aging-related conditions, using what’s called epigenetic editing.

Most of the gene editing technologies being used today slice or nick the DNA strand and make permanent changes to the biological building blocks of genes. Moonwalk, however, plans to alter the activity of genes by focusing on chemical changes. The company is targeting the surrounding chemicals that influence how genes act. This can be done through chemical processes methylation, which turns genes on, or demethylation, which turns genes off.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： NYU Langone launches private ChatGPT for its health care data

focus

WSS

U.K. Biobank has 500,000 peoples' genome sequences available

Winners, losers from Medicare’s list of drugs subject to price talks

What AAP's gender

How Long Island became the ‘eugenics capital of the world’

Complete sequence of Y chromosome published for first time

Drug firms test therapies to halt Alzheimer’s before symptoms arise

hotspot

hotspot

focus

23andMe had bad news about my health. I wish a person had delivered it

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Fetal surgery at risk from Dobbs and new abortion restrictions

Jerome Adams on the need for new antivirals for Covid

Takeda, Janssen join wearable maker to measure scratching

BioMarin wins approval for gene therapy to treat hemophilia A

How to make AI work for medicine

Medicare proposal to cover medical devices draws a mixed reaction

Why more medical students aren't specializing in primary care

leisure time

Appeals court upholds limits to abortion pill

Australia’s approach to dialysis celebrates life

Cigna, Humana reportedly in talks to merge

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

As pharma fights Medicare drug negotiation, hospitals, docs silent

focus

Wikipedia

focus

focus